Thomas Engelbrecht Nordkild Jonassen

Title: Thomas Engelbrecht Nordkild Jonassen: Innovator in Arthritis Treatment

Introduction

Thomas Engelbrecht Nordkild Jonassen is a notable inventor based in Holte, Denmark. He has made significant contributions to the field of medicine, particularly in the treatment of arthritic diseases. With a total of 2 patents, Jonassen's work focuses on innovative compositions and methods that aim to improve patient outcomes.

Latest Patents

Jonassen's latest patents include a groundbreaking invention titled "Combination treatment of arthritic disease." This invention relates to a composition that comprises, either separately or together, methotrexate (MTX) and (E)-N-trans-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium acetate (AP1189), or pharmaceutically acceptable derivatives thereof. This composition is designed for use in treating arthritis diseases, such as rheumatoid arthritis. Another significant patent is "Polymorphs of phenyl pyrrole aminoguandium salts," which discloses crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts that exhibit high solubility. This disclosure also relates to the use of these crystalline forms in medicine.

Career Highlights

Jonassen is currently associated with Synact Pharma Aps, where he continues to develop innovative solutions for medical challenges. His work is characterized by a commitment to advancing therapeutic options for patients suffering from chronic conditions.

Collaborations

Some of Jonassen's notable coworkers include Thomas Boesen and Hayley Ann Reece. Their collaborative efforts contribute to the innovative environment at Synact Pharma Aps.

Conclusion

Thomas Engelbrecht Nordkild Jonassen is a distinguished inventor whose work in arthritis treatment showcases his dedication to improving healthcare through innovation. His patents reflect a deep understanding of medical needs and a commitment to developing effective solutions.